Does Radiosurgery Shrink or Stop Schwannoma Growth?
At a Glance
Stereotactic radiosurgery usually controls a vestibular schwannoma by stopping its growth rather than removing it. The tumor may shrink slowly or stay the same size, and temporary MRI swelling can occur, so doctors use repeat scans over time to judge the response.
The primary goal of stereotactic radiosurgery (SRS) is to stop a benign schwannoma from growing, not to make it disappear completely. In medicine, this goal is called local control [1]. While some tumors do gradually shrink over several years, many remain roughly the same size but become inactive. It is extremely rare for a schwannoma to vanish completely after radiosurgery [2].
Note: The statistics and timelines below are based primarily on research regarding vestibular schwannomas (also known as acoustic neuromas). If you have a schwannoma on a different nerve (such as a spinal or trigeminal schwannoma), ask your doctor how these numbers apply to your specific condition.
How Radiosurgery Affects the Tumor
Unlike traditional surgery, which physically removes the mass, radiosurgery works by delivering highly focused radiation to the tumor [3]. This damages the DNA of the tumor cells, preventing them from replicating [4]. Because schwannomas are slow-growing, the effects of this DNA damage unfold slowly.
Radiosurgery is highly effective at achieving long-term local control. Several large, long-term studies report that SRS successfully stops tumor growth in 90% to 93% of vestibular schwannoma cases at 5 to 10 years after treatment [5][6].
When tracking exactly what happens to the physical volume of the tumor over time, different studies report varying numbers depending on how long patients were followed. In one study tracking patients for an average of 4.5 years:
- About 47% of tumors eventually showed some degree of shrinkage [2].
- About 41% remained stable [2].
- About 12% continued to progress and grow, requiring further intervention [2].
Even if the overall size of the tumor remains stable, the inside of the tumor may be changing. On an MRI, a radiologist might note a loss of contrast enhancement (the tumor absorbs less of the injected MRI dye) or central necrosis (the center of the tumor appearing dark, indicating damaged or dying tissue) [7][4]. While these can be encouraging signs that the tumor is responding to radiation, your care team will interpret them alongside changes in tumor size and your physical symptoms [4][8].
The Swelling Phase: Pseudoprogression
One of the most important things to expect after radiosurgery is that the tumor might actually look larger on early follow-up MRIs. This temporary swelling is called pseudoprogression [9].
In one study of vestibular schwannomas, this temporary swelling occurred in about 44% of cases [9]. It usually begins around one year after treatment and can take up to 3.5 years to reach its peak size [9][10]. Over several years, this swelling typically resolves. In another study focusing specifically on tumors that enlarged after SRS, 83% were found to be experiencing temporary pseudoprogression rather than true, unstoppable growth [11].
Because of this swelling phase, a single MRI showing an enlarged tumor during the first three to four years does not automatically mean the radiosurgery failed [9][12]. Serial imaging—comparing multiple MRIs over time—is often required to tell the difference between temporary swelling and true tumor growth [12].
When to Contact Your Doctor: While swelling on an MRI can be harmless pseudoprogression, swelling can sometimes press on nearby nerves or brain structures. Do not passively wait for your next scheduled scan if you feel worse. Contact your care team promptly if you develop new or worsening symptoms, such as:
- Severe or worsening headaches, or repeated vomiting
- Sudden changes in hearing or balance
- Facial weakness, numbness, or spasms [13]
- Trouble swallowing, confusion, or marked sleepiness
Long-Term Monitoring and Success
Because radiosurgery leaves the tumor in your body, you will need routine MRI scans for many years to monitor its behavior [14]. The frequency of these scans may decrease over time depending on your tumor’s stability and your doctor’s protocols. Even if a tumor shrinks initially, there is a very rare chance of late regrowth, making long-term surveillance important [15][14].
Success is generally defined as the tumor no longer growing (radiographic control) combined with the management of your symptoms [3]. It is important to know that while SRS can stop the tumor from growing, symptoms you already have (like hearing loss or tinnitus) may not reverse, and can sometimes change independently of the tumor’s size.
Common questions in this guide
What is stereotactic radiosurgery supposed to do to a schwannoma?
How likely is a vestibular schwannoma to stay controlled after SRS?
Why did my schwannoma look bigger on an MRI after radiosurgery?
How do doctors know whether swelling after SRS is temporary?
Can radiosurgery improve hearing loss or tinnitus caused by a schwannoma?
How long do I need MRI scans after schwannoma radiosurgery?
Which symptoms after SRS mean I should call my doctor?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What type of schwannoma do I have, and how closely do the statistics for vestibular schwannomas apply to my case?
- 2.If my tumor swells after treatment, how will we determine whether it is pseudoprogression or true continued growth?
- 3.What specific MRI signs, such as central necrosis or changes in dye uptake, will you look for to tell if the tumor is responding to radiation?
- 4.How often will I need follow-up MRIs in the first five years compared to later in my life?
- 5.Which specific new or worsening symptoms should prompt me to call your office immediately rather than waiting for my next scan?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
Gamma Knife radiosurgery for vestibular schwannomas.
Kondziolka D, Golfinos JG
Handbook of clinical neurology 2025; (212()):259-266 doi:10.1016/B978-0-12-824534-7.00007-X.
PMID: 41052848 - 2
Stereotactic radiosurgery vs. fractionated radiotherapy for large vestibular schwannomas: should FSRT be the preferred treatment?
Akkus Yildirim B, Beduk Esen CS, Pekgoz OF, et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025; (27(7)):3198-3203 doi:10.1007/s12094-024-03790-0.
PMID: 39676098 - 3
Salvage radiosurgery following subtotal resection of vestibular schwannomas: does timing influence tumor control?
Dhayalan D, Perry A, Graffeo CS, et al.
Journal of neurosurgery 2023; (138(2)):420-429 doi:10.3171/2022.5.JNS22249.
PMID: 35907189 - 4
Longitudinal Radiographic Outcomes of Vestibular Schwannoma in Single and Fractionated Stereotactic Radiosurgery: A Retrospective Cohort Study.
Khattab MH, Newman NB, Wharton DM, et al.
Journal of neurological surgery. Part B, Skull base 2020; (81(3)):308-316 doi:10.1055/s-0039-1692642.
PMID: 32500007 - 5
Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
Lo A, Ayre G, Ma R, et al.
International journal of radiation oncology, biology, physics 2018; (100(2)):443-451 doi:10.1016/j.ijrobp.2017.09.024.
PMID: 29066124 - 6
Risk analysis of radiosurgery for vestibular schwannoma: Systematic review and comparative study of 10-year outcomes.
Guy KM, Pace AA, Tsang DS, Volsky PG
Neuro-oncology advances 2025; (7(1)):vdae191 doi:10.1093/noajnl/vdae191.
PMID: 39906175 - 7
Gamma Knife Radiosurgery-Induced Acute Facial Palsy in Vestibular Schwannoma: A Case Report.
Can OB, Ruksen M
Turkish neurosurgery 2026; (36(4)):620-623 doi:10.5137/1019-5149.JTN.49629-25.2.
PMID: 42541788 - 8
3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma.
Schneider T, Chapiro J, Lin M, et al.
European radiology 2016; (26(3)):849-57 doi:10.1007/s00330-015-3895-9.
PMID: 26139318 - 9
Temporal Dynamics of Pseudoprogression After Gamma Knife Radiosurgery for Vestibular Schwannomas-A Retrospective Volumetric Study.
Breshears JD, Chang J, Molinaro AM, et al.
Neurosurgery 2019; (84(1)):123-131 doi:10.1093/neuros/nyy019.
PMID: 29518221 - 10
Tufts Medical Center Experience With Long-Term Follow-Up of Vestibular Schwannoma Treated With Gamma Knife Stereotactic Radiosurgery: Novel Finding of Delayed Pseudoprogression.
Wage J, Mignano J, Wu J
Advances in radiation oncology 2021; (6(4)):100687 doi:10.1016/j.adro.2021.100687.
PMID: 34409200 - 11
A retrospective study demonstrating the growth patterns and the pseudoprogression temporal classification after stereotactic radiosurgery for sporadic vestibular schwannomas.
El-Shehaby AMN, Reda WA, Abdel Karim KM, et al.
Scientific reports 2025; (15(1)):18187 doi:10.1038/s41598-025-03095-4.
PMID: 40415100 - 12
Distinguishing pseudoprogression from true tumor growth after stereotactic surgery in vestibular schwannoma: a volumetric and clinical trajectory analysis.
Inggas MAM, Apriani S, Hendriansyah L, Wijaya JH
Radiation oncology (London, England) 2025; (20(1)):185 doi:10.1186/s13014-025-02753-1.
PMID: 41382184 - 13
Prediction of treatment failure and early identification of tumor progression after Gamma-Knife radiosurgery in vestibular schwannoma: A retrospective cohort study.
Fabbrocini L, Hurth H, van Eck ATCJ, et al.
Neuro-oncology advances 2025; (7(1)):vdaf139 doi:10.1093/noajnl/vdaf139.
PMID: 40756668 - 14
Delayed Vestibular Schwannoma Regrowth Following Shrinkage After Stereotactic Radiosurgery: Implication for Life-Long Surveillance.
Stapleton E, Crowther JA, Locke R, Kontorinis G
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2017; (38(2)):260-263 doi:10.1097/MAO.0000000000001280.
PMID: 28068303 - 15
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Radiosurgery and Radiation Therapy in the Management of Patients With Vestibular Schwannomas.
Germano IM, Sheehan J, Parish J, et al.
Neurosurgery 2018; (82(2)):E49-E51 doi:10.1093/neuros/nyx515.
PMID: 29309637
This page is for informational purposes only and does not constitute medical advice. Your treating team should interpret your MRI results, symptoms, and treatment response for your specific schwannoma.
Get notified when new evidence is published on Benign schwannoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.